Ronnda L. Bartel

1.6k citations

21 papers · 1.2k indexed · h-index 13

Co-authors: R. T. BORCHARDT Kenneth L. Audus Ismael J. Hidalgo John F. Hansbrough Gail K. Naughton Ron Cohen Richard L. Spielvogel Matthew Cooper
Topics: Mesenchymal stem cell research (5 papers)Angiogenesis and VEGF in Cancer (4 papers)Advancements in Transdermal Drug Delivery (3 papers)
Cited by: Rehabilitation Genetics Pharmaceutical Science
Journals: Journal of the American Chemical Society Circulation Biomaterials
Partner nations: United States United Kingdom

In The Last Decade

Ronnda L. Bartel

21 papers receiving 1.1k citations

Peers

Countries citing papers authored by Ronnda L. Bartel

Since Specialization

Citations

This map shows the geographic impact of Ronnda L. Bartel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronnda L. Bartel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronnda L. Bartel more than expected).

Fields of papers citing papers by Ronnda L. Bartel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronnda L. Bartel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronnda L. Bartel. The network helps show where Ronnda L. Bartel may publish in the future.

Co-authorship network of co-authors of Ronnda L. Bartel

This figure shows the co-authorship network connecting the top 25 collaborators of Ronnda L. Bartel. A scholar is included among the top collaborators of Ronnda L. Bartel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronnda L. Bartel. Ronnda L. Bartel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 15864: Clinical Trial of Autologous CD34 Cell Therapy for Treatment of Coronary Microvascular Dysfunction in Patients With Angina and Non-Obstructive Coronary Arteries 2019 ·Circulation ·C. Noel Bairey Merz,Timothy D. Henry,Janet Wei,Michel Corban,Sandy Joung,(unknown),(unknown),(unknown),Ronnda L. Bartel,William K. Sietsema,Douglas W. Losordo,Amir Lerman	1
2	Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases 2015 ·Stem Cell Research & Therapy ·(unknown),(unknown),(unknown),Ronnda L. Bartel,Ross Tubo	10
3	From Bench to Bedside: Review of Gene and Cell-Based Therapies and the Slow Advancement into Phase 3 Clinical Trials, with a Focus on Aastrom’s Ixmyelocel-T 2013 ·Stem Cell Reviews and Reports ·Ronnda L. Bartel,(unknown),(unknown),(unknown),Sharon Watling,(unknown)	8
4	Stem Cell Therapy for Craniofacial Bone Regeneration: A Randomized, Controlled Feasibility Trial 2013 ·Cell Transplantation ·Darnell Kaigler,Giorgio Pagni,Chan Ho Park,Thomas Braun,(unknown),(unknown),Susan A. Tarlé,Ronnda L. Bartel,William V. Giannobile	142
5	Ixmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophages 2013 ·Stem Cell Research & Therapy ·(unknown),(unknown),Ronnda L. Bartel	19
6	Potential beneficial effects of ixmyelocel-T in the treatment of atherosclerotic diseases 2013 ·Stem Cell Research & Therapy ·(unknown),(unknown),(unknown),Ronnda L. Bartel	4
7	Cellular Therapy With Ixmyelocel-T to Treat Critical Limb Ischemia: The Randomized, Double-blind, Placebo-controlled RESTORE-CLI Trial 2012 ·Molecular Therapy ·Richard J. Powell,William A. Marston,Scott A. Berceli,Raul J. Guzman,Timothy D. Henry,Amy Longcore,Theresa Stern,Sharon Watling,Ronnda L. Bartel	115
8	Abstract 280: Evidence for the Beneficial Effects of Ixmyelocel-T in the Treatment of Critical Limb Ischemia 2012 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown),(unknown),Ronnda L. Bartel	1
9	The Aastrom experience 2012 ·Stem Cell Research & Therapy ·Ronnda L. Bartel,(unknown),(unknown),Amy Longcore,(unknown),Theresa Stern,Sharon Watling,(unknown)	21
10	Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia 2011 ·Journal of Vascular Surgery ·Richard J. Powell,Anthony J. Comerota,Scott A. Berceli,Raul J. Guzman,Timothy D. Henry,Edith Tzeng,Omaida C. Velázquez,William A. Marston,Ronnda L. Bartel,Amy Longcore,Theresa Stern,Sharon Watling	88
11	Angiogenic and Osteogenic Potential of Bone Repair Cells for Craniofacial Regeneration 2010 ·Tissue Engineering Part A ·Darnell Kaigler,Giorgio Pagni,Chan Ho Park,Susan A. Tarlé,Ronnda L. Bartel,William V. Giannobile	50
12	Culturing Keratinocytes and Fibroblasts in a Three-Dimensional Mesh Results in Epidermal Differentiation and Formation of a Basal Lamina-Anchoring Zone 1993 ·Journal of Investigative Dermatology ·(unknown),Ronnda L. Bartel,(unknown),Jerome S. Perlish,Ewan MacDonald,L. C. Handler,(unknown),Raúl Fleischmajer	105
13	Characterization, Barrier Function, and Drug Metabolism of an In Vitro Skin Model 1993 ·Journal of Investigative Dermatology ·Sandra R. Slivka,Lee K. Landeen,(unknown),Michael Zimber,Ronnda L. Bartel	85
14	Composite Grafts of Human Keratinocytes Grown on a Polyglactin Mesh-Cultured Fibroblast Dermal Substitute Function as a Bilayer Skin Replacement in Full-Thickness Wounds on Athymic Mice 1993 ·Journal of Burn Care & Rehabilitation ·John F. Hansbrough,(unknown),Glenn Greenleaf,Ronnda L. Bartel	58
15	Physiological Cultured Skin Substitutes for Wound Healing 1991 ·MRS Proceedings ·Craig R. Halberstadt,(unknown),Ronnda L. Bartel,Ron Cohen,Gail K. Naughton	7
16	In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh 1991 ·Biomaterials ·Matthew Cooper,John F. Hansbrough,Richard L. Spielvogel,Ron Cohen,Ronnda L. Bartel,Gail K. Naughton	157
17	Permeability characteristics of cultured mouse keratinocytes compared to hairless mouse skin 1991 ·International Journal of Pharmaceutics ·(unknown),Ronnda L. Bartel,Ronald T. Borchardt	6
18	The Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism Studies 1990 ·Pharmaceutical Research ·Kenneth L. Audus,Ronnda L. Bartel,Ismael J. Hidalgo,R. T. BORCHARDT	220
19	Partial Characterization of Phospholipase C Activity in Normal, Psoriatic Uninvolved, and Lesional Epidermis 1987 ·Journal of Investigative Dermatology ·Ronnda L. Bartel,Cynthia L. Marcelo,John J. Voorhees	45
20	Mechanism of action of S-adenosyl-L-homocysteine hydrolase. Measurement of kinetic isotope effects using adenosine-3'-d and S-adenosyl-L-homocysteine-3'-d as substrates 1985 ·Journal of the American Chemical Society ·Achintya K. Sinhababu,Ronnda L. Bartel,(unknown),Ronald T. Borchardt	16

About Ronnda L. Bartel

Ronnda L. Bartel is a scholar working on Pharmaceutical Science, Genetics and Rehabilitation, having authored 21 papers that have together received 1.2k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Advancements in Transdermal Drug Delivery (3 papers). The work is most often cited by research in Rehabilitation (209 citations), Genetics (215 citations) and Pharmaceutical Science (112 citations). Ronnda L. Bartel has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include R. T. BORCHARDT, Kenneth L. Audus, Ismael J. Hidalgo, John F. Hansbrough, Gail K. Naughton, Ron Cohen, Richard L. Spielvogel, Matthew Cooper, Susan A. Tarlé and William V. Giannobile. Their work appears in journals such as Journal of the American Chemical Society, Circulation and Biomaterials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact